PAVM - PAVmed Inc.

10.5
0.350   3.333%

Share volume: 40,351
Last Updated: 03-04-2026
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies: -0.01%

PREVIOUS CLOSE
CHG
CHG%
$10.15
0.35
0.03%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
47%
Profitability 50%
Dept financing 25%
Liquidity 7%
Performance 60%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
4.37%
1 Month
-0.76%
3 Months
3,091.49%
6 Months
2,256.90%
1 Year
1,488.50%
2 Year
240.91%
Key data
Stock price
$10.50
P/E Ratio 
0.00
DAY RANGE
$9.75 - $10.63
EPS 
$0.39
52 WEEK RANGE
$0.21 - $28.44
52 WEEK CHANGE
$1,467.16
MARKET CAP 
9.453 M
YIELD 
N/A
SHARES OUTSTANDING 
29.672 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-12-2025
BETA 
1.25
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$37,143
AVERAGE 30 VOLUME 
$122,402
Company detail
CEO: Lishan Aklog
Region: US
Website: pavmed.com
Employees: 90
IPO year: 2016
Issue type: Common Stock
Market: XNAS
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing

PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE)

Recent news